Analyze CD8+ T cell responses to SARS-CoV-2 with our new MHC Class I QuickSwitch™ tetramer kit and peptides bundles.Learn More
Currently, MBLI products are delivered with the product data sheet included in the package. This is an announcement that we will stop including the product data sheet in the package for certain products. It will be applied sequentially to batches manufactured after April 2022 for some products. You can download the product data sheet from our website whenever you need. Allow us to apologize for any inconvenience this may have caused you.
Many of our products currently utilize clear-color vial tube labels. We will be changing the color of the labels to white for production lots manufactured after February 1, 2022. The product description written on the label and product itself will not be changed.
MBL International has been actively monitoring COVID-19 developments and want to assure you that the safety of our team and our customers is our primary focus. The COVID-19 pandemic presents a very fluid situation with challenges for each of us.
Learn more about how MBL International is responding to the safety of our employees and needs of our customers.
Explore our video library of webinars focused on different life science research topics and applications. All webinars are presented by our scientists at MBL International.
Tue, 02 Aug 2022 16:07:46 GMT
Wed, 16 Jun 2021 12:45:47 GMT
Thu, 18 Mar 2021 20:17:21 GMT
Isotype control antibodies are negative controls used to accurately measure antibody drug effects and efficacy for in vitro and in vivo monoclonal antibody (mAb) studies. Isotype controls match the test/primary antibody characteristics, but are raised against antigens not found in common preclinical species; this means that isotype controls lack specificity for the target antigen.
In both in vivo and in vitro assays, a signal can result from various binding events. In order to accurately interpret assay results, it is critical to differentiate between binding events such as:
mAb binding in an antigen-dependent specific manner.
mAb binding in a non-antigen dependent manner, due to interaction with Fc receptors (FcR) or other proteins.
Isotype control antibodies provide an ideal negative control for mAb efficacy studies, enabling researchers to accurately distinguish between non-specific background and specific antibody signal. Read more
MBL International is here to work with you and advance your unique research needs using custom services. We can help with Immuno-monitoring services using MHC Tetramers and Cytokines. Contact us today for more information.